Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Linzess

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 875,605Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ironwood Reaffirms 2025 LINZESS Sales, Ups EBITDA Outlook
    Ironwood Reaffirms 2025 LINZESS Sales, Ups EBITDA Outlook

    25 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425289111/en/Ironwood-Pharmaceuticals-Reiterates-Full-Year-2025-LINZESS-U.S.-Net-Sales-Guidance-and-Raises-Adjusted-EBITDA-Guidance

    BUSINESSWIRE
    25 Apr 2025
    Share Share
    Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
    Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

    08 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240808744786/en

    BUSINESSWIRE
    08 Aug 2024
    Share Share
    Ironwood Announces Publication of Linaclotide Phase III Data
    Ironwood Announces Publication of Linaclotide Phase III Data

    08 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240108343579/en

    BUSINESSWIRE
    08 Jan 2024
    Share Share
    Ironwood to Present New Data at NASPGHAN Annual Meeting
    Ironwood to Present New Data at NASPGHAN Annual Meeting

    05 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231005868701/en

    BUSINESSWIRE
    05 Oct 2023
    Share Share
    FDA approves first treatment for pediatric functional constipation
    FDA approves first treatment for pediatric functional constipation

    13 Jun 2023

    // FDA

    https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-pediatric-functional-constipation

    FDA
    13 Jun 2023
    Share Share
    Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS
    Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS

    12 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230612173180/en

    BUSINESSWIRE
    12 Jun 2023
    Share Share